| Axon ID |
Name |
Description |
From price |
|
1358
|
BIRB 796
|
MAPK inhibitor (p38 specific) |
€65.00 |
|
1386
|
CHIR99021
|
GSK-3 inhibitor |
€60.00 |
|
1408
|
PD0325901
|
MEK1 and MEK2 inhibitor |
€50.00 |
|
1683
|
Y 27632 dihydrochloride
|
ROCK1 and ROCK2 inhibitor |
€65.00 |
|
2128
|
Stem Cell 2i inhibitor Set
|
Set of MEK inhibitor PD0325901 (Axon 1408) and GSK-3 inhibitor CHIR99021 (Axon 1386) |
€90.00 |
|
2129
|
Stem Cell 3i inhibitor Set
|
Set of FGFR inhibitor SU5402 (Axon 1667), MEK inhibitor PD184352 (Axon 1368) and GSK-3 inhibitor CHIR99021 (Axon 1386) |
€130.00 |
|
5004
|
Stem Cell LSB inhibitor Set
|
Set of BMP inhibitor LDN 193189 (Axon 1509) and TGF-β inhibitor SB 431542 (Axon 1661) |
€90.00 |
|
5005
|
Stem Cell LSC inhibitor Set
|
Set of LDN 193189 HCl, SB 431542 and CHIR99021, inhibitors of BMP, TGF-β, and GSK-3 resp. |
€130.00 |
|
5006
|
Stem Cell CSD inhibitor Set
|
Set of CHIR99021, SU5402, and DAPT, inhibitors of GSK-3, FGFR, and γ-secretase, resp. |
€140.00 |
|
5007
|
Stem Cell 5i inhibitor Set
|
Set of five inhibitors for neural differentiation of human pluripotent stem cells. |
€200.00 |
|
5008
|
Stem Cell RG-BIX inhibitor Set
|
Set of RG 108 and BIX 01294 HCl, inhibitors of DNMT and HMTase, respectively |
€60.00 |
|
5009
|
Stem Cell 4i inhibitor Set
|
Set of Thiazovivin, SB 431542, PD0325901, and CHIR99021 (inhibitors of ROCK, TGF-β, MEK, and GSK-3 resp.) |
€170.00 |
|
2466
|
Gö 6983
|
Broad spectrum PKC inhibitor lacking inhibitory effect for PKCμ |
€90.00 |
|
2519
|
SP 600125
|
Selective, reversible, and ATP-competitive JNK inhibitor |
€70.00 |
|
5011
|
Naive Stem Cell 5i inhibitor Set
|
Set of five inhibitors for the induction and maintenance of human naive stem cell pluripotency |
€200.00 |
|
2753
|
CCG 232601
|
Rho/MRTF/SRF transcriptional pathway inhibitor |
€160.00 |
|
2780
|
KD025
|
Selective ATP-competitive inhibitor of ROCK2 |
€95.00 |
|
2856
|
BMS 582949
|
Inhibitor of p38α MAPK |
€155.00 |
|
2949
|
JNK inhibitor VIII
|
Selective, ATP-competitive, and cell-permeable JNK inhibitor |
€105.00 |
|
2981
|
B106
|
Potent and selective PKC-δ inhibitor |
€135.00 |
|
3153
|
BRD5648
|
Negative control compound of BRD0705 as a GSK3α inhibitor |
€180.00 |
|
3154
|
rac-BRD0705
|
GSK3α inhibitor |
€120.00 |
|
2931
|
BRD0705
|
First-in-class, paralog selective GSK3α inhibitor |
€210.00 |
|
3092
|
CCG-203971
|
Rho/MRTF/SRF transcriptional pathway inhibitor |
€60.00 |
|
3183
|
SR-318
|
Highly potent and selective type-II p38 α/β inhibitor |
€120.00 |
|
3346
|
BIX02188
|
Potent MEK5 inhibitor |
€110.00 |
|
3440
|
MK2 inhibitor III
|
Potent and selective MK-2 inhibitor |
€120.00 |
|
3579
|
Tideglusib
|
GSK-3 inhibitor |
€60.00 |
|
3625
|
GNE-3511
|
Potent, selective, orally bioavailable and brain-penetrant DLK inhibitor |
€90.00 |
|
3697
|
Binimetinib
|
Potent, selective, non-ATP-competitive and orally available allosteric inhibitor of MEK1/2 |
€60.00 |
|
3620
|
MAPK13 inhibitor compound 61
|
MAPK13 inhibitor (p38δ specific) |
€140.00 |
|
3848
|
Fasudil hydrochloride
|
Orally active ROCK inhibitor; Ca2+ channel antagonist |
€50.00 |
|
3874
|
RDEA119
|
Potent and highly selective small molecule allosteric MEK inhibitor |
Inquire |
|
3986
|
N-Desmethyltamoxifen hydrochloride
|
Metabolite of Tamoxifen (Axon 3252); PKC inhibitor |
€180.00 |
|
3939
|
Bisindolylmaleimide IV
|
Potent PKC inhibitor |
€120.00 |
|
3936
|
Bisindolylmaleimide I
|
Potent and selective PKC inhibitor |
€120.00 |
|
4148
|
GDC-0973
|
Orally bioavailable, potent and selective small-molecule inhibitor of mitogen-activated protein kinase 1 |
Inquire |
|
4217
|
AS-703026
|
Potent, selective and orally bioavailable small molecular inhibitor of MEK1/2 |
Inquire |
|
4219
|
VX-702
|
Orally bioavailable p38 MAP kinase inhibitor |
Inquire |